CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-449

If he posted the actual fundamentals he would have to become bullish, as you can't really shout sell whilst talking about 80% growth and rapidly improving operating performance (amongst all the other FA related stuff). This company is ticking every single box there is, and in my view we will be seeing significant buying within the next few weeks with the annual report approaching fast. I really can't imagine how it could remain so low with the results we have, at the moment it's perhaps understandable as we are still waiting on the audited figures, but when those arrive there should be no excuse for this being under 50c. Far too undervalued IMO